Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer

Clinical trial NCT03181100 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03181100
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Thyroid Gland Carcinoma Poorly Differentiated Thyroid Gland Carcinoma Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v8 Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8 Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8 Thyroid Gland Anaplastic Carcinoma Unresectable Thyroid Gland Carcinoma

Start date: 2017-07-27
Primary completion: 2027-07-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.